Fluctuations in serological hepatitis C virus levels in HIV patients

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
SOC BRASILEIRA MEDICINA TROPICAL
Autores
SILVA, Vanessa Cristina Martins
CALUX, Samira Julien
LEMOS, Marcilio Figueiredo
COMPRI, Adriana Parise
OBA, Isabel Takano
MOREIRA, Regina Celia
Citação
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, v.51, n.6, p.737-741, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) have identical transmission routes, explaining the high prevalence of coinfections. The main aim of this study was to detect fluctuations in serological HCV levels in HIV patients. Methods: We analyzed samples of 147 patients who attended an outpatient service that supports HIV/AIDS patients in Sao Paulo city. We also recruited 22 HCV-monoinfected patients who attended the Instituto Adolfo Lutz Laboratory in Sao Paulo city, to compare the test results. Serological testing of the blood samples was performed for the detection of HCV antibodies. The samples were then analyzed using real-time PCR for RNA viral quantification and sequencing. Results: We found that 13.6% of the study population was coinfected with HIV and HCV. In 20% of coinfected patients, fluctuations in serology results were detected in samples collected during the follow-up. No changes in anti-HCV serological markers were observed in HCV-monoinfected patients. An HCV viral load was detected in 9,5% of the samples collected from HIV patients. Conclusions: Our findings provide important clinical data to public health professionals and highlight the importance of periodic monitoring of HCV/HIV coinfected patients.
Palavras-chave
Fluctuation, Hepatitis C virus, Serology, Human immunodeficiency virus
Referências
  1. Afdhal NH, 2004, SEMIN LIVER DIS, V24, P3, DOI 10.1055/s-2004-832922
  2. Beld M, 1999, BLOOD, V94, P1183
  3. Busch MP, 2003, JAMA-J AM MED ASSOC, V289, P959, DOI 10.1001/jama.289.8.959
  4. Carvalho AC, 2014, R INTERD, V7, P55
  5. Chevaliez Stephane, 2006, Int J Med Sci, V3, P35
  6. Dieterich DT., 1999, AM J MED S, V107, P79
  7. Easterbrook PJ, 2017, CURR OPIN HIV AIDS, V12, P302, DOI 10.1097/COH.0000000000000370
  8. Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227
  9. Martins Regina M.B., 2006, Rev. Inst. Med. trop. S. Paulo, V48, P53, DOI 10.1590/S0036-46652006000100012
  10. Martins T, 2011, REV ASSOC MED BRAS, V57, P107, DOI 10.1590/S0104-42302011000100024
  11. Mendes-Correa Maria Cassia J., 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P15, DOI 10.1590/S0036-46652001000100003
  12. Mendes-Correa Maria Cassia J., 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P81, DOI 10.1590/S0036-46652000000200004
  13. Ministry of Health (MS), 2017, CLIN PROT THER GUID
  14. Ministry of Health (MS), 2017, EP B VIR HEP
  15. Moreira R, 2003, CAN J MICROBIOL, V49, P503, DOI 10.1139/W03-065
  16. Pereira LMMB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-60
  17. Sabin CA, 1997, J INFECT DIS, V175, P164, DOI 10.1093/infdis/175.1.164
  18. Spengler U, 1998, J HEPATOL, V29, P1023, DOI 10.1016/S0168-8278(98)80135-9
  19. Sulkowski MS, 2000, CLIN INFECT DIS, V30, pS77, DOI 10.1086/313842
  20. Villar Livia Melo, 2015, World J Virol, V4, P323, DOI 10.5501/wjv.v4.i4.323
  21. Wolff FH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010494
  22. World and Health Organization (WHO), 2017, HEP C
  23. Zylberberg H, 1996, CLIN INFECT DIS, V23, P1117, DOI 10.1093/clinids/23.5.1117